Osaic Holdings
TRVI icon

Osaic Holdings’s Trevi Therapeutics TRVI Stock Holding History

Osaic Holdings’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9K Buy
1,712
+174
+11% +$2.53K ﹤0.01% 5805
2026
Q1 		$18.3K Buy
+1,538
New +$17.2K ﹤0.01% 5913
2021
Q1 		– Sell
-1,000
Closed -$2K – 6949
2020
Q4 		$2K Hold
1,000
– – ﹤0.01% 6114
2020
Q3 		$4K Buy
+1,000
New +$4.7K ﹤0.01% 5664

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Osaic Holdings's TRVI Position: Q2 2026 in Review

Osaic Holdings increased its Trevi Therapeutics (TRVI) stake by 11% in Q2 2026, buying an estimated $2.53K and bringing the position to 1,712 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5805.

Osaic Holdings first reported a position in TRVI in Q3 2020 and has held it in 4 quarters since. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Osaic Holdings held 1,712 shares of Trevi Therapeutics worth $31.9K as of Q2 2026.
  • Osaic Holdings bought 174 Trevi Therapeutics shares in Q2 2026, an estimated $2.53K.
  • Trevi Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5805 holding.
  • Osaic Holdings first reported a position in Trevi Therapeutics in Q3 2020 and has held it in 4 quarters since.
  • 218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.